Hiroko Gotoda

481 total citations
22 papers, 352 citations indexed

About

Hiroko Gotoda is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Hiroko Gotoda has authored 22 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Hiroko Gotoda's work include Renal cell carcinoma treatment (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Hiroko Gotoda is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Hiroko Gotoda collaborates with scholars based in Japan, United States and Taiwan. Hiroko Gotoda's co-authors include Shunji Muraoka, Toshihiro Sato, Satoshi Nagamori, Nobuo Shinohara, T. Furuno, Yoji Nagashima, Naoto Kuroda, Yukichi Tanaka, Rieko Ijiri and Makiko Ohyama and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and The American Journal of Surgical Pathology.

In The Last Decade

Hiroko Gotoda

18 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Gotoda Japan 10 259 80 75 69 56 22 352
C. Cellier France 10 179 0.7× 66 0.8× 63 0.8× 60 0.9× 25 0.4× 22 296
Thierry Dujardin Canada 13 269 1.0× 88 1.1× 74 1.0× 47 0.7× 92 1.6× 27 445
Turki Al‐Hussain Saudi Arabia 10 188 0.7× 130 1.6× 82 1.1× 76 1.1× 14 0.3× 33 344
Ahmad BaniHani United States 10 98 0.4× 177 2.2× 158 2.1× 51 0.7× 41 0.7× 20 432
Jasneet Singh Bhullar United States 11 165 0.6× 105 1.3× 229 3.1× 72 1.0× 29 0.5× 39 440
Eva Jančová Czechia 11 138 0.5× 75 0.9× 23 0.3× 203 2.9× 23 0.4× 23 440
C. R. Staalman Netherlands 7 80 0.3× 76 0.9× 154 2.1× 59 0.9× 36 0.6× 14 419
A. Karim Touijer United States 9 248 1.0× 97 1.2× 224 3.0× 170 2.5× 18 0.3× 11 449
Maria Carmen Affinita Italy 11 120 0.5× 75 0.9× 53 0.7× 67 1.0× 11 0.2× 28 279
Marie-Josèe Hébert Canada 7 116 0.4× 105 1.3× 37 0.5× 32 0.5× 24 0.4× 9 296

Countries citing papers authored by Hiroko Gotoda

Since Specialization
Citations

This map shows the geographic impact of Hiroko Gotoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Gotoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Gotoda more than expected).

Fields of papers citing papers by Hiroko Gotoda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Gotoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Gotoda. The network helps show where Hiroko Gotoda may publish in the future.

Co-authorship network of co-authors of Hiroko Gotoda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Gotoda. A scholar is included among the top collaborators of Hiroko Gotoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Gotoda. Hiroko Gotoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishida, Mutsumi, Yusuke Kudo, Aya Matsui, et al.. (2023). Ultrasonographic diagnosis of cystitis glandularis with severe intestinal metaplasia. Journal of Clinical Ultrasound. 51(8). 1397–1400.
3.
Takahashi, Hiroyuki, et al.. (2020). A Case of Bromoderma Caused by a Commercial Sadative Resulting in a Difficulty for a Diagnosis. The Nishinihon Journal of Dermatology. 82(5). 343–347.
4.
Suzuki, Takuto, et al.. (2018). Pneumatosis Cystoides Intestinalis Secondary to Sunitinib Treatment for Gastrointestinal Stromal Tumor. Case Reports in Gastroenterology. 12(2). 432–438. 6 indexed citations
5.
Kato, Takashi, Shin Ichihara, Hiroko Gotoda, et al.. (2017). Imprint cytology of clear cell sarcoma‐like tumor of the gastrointestinal tract in the small intestine: A case report. Diagnostic Cytopathology. 45(12). 1137–1141. 8 indexed citations
6.
Tamura, Tomoki, Yuka Kato, Kadoaki Ohashi, et al.. (2017). Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations. Biochemical and Biophysical Research Communications. 495(1). 360–367. 15 indexed citations
7.
Kubo, Toshio, Hiroko Gotoda, Tomoki Tamura, et al.. (2016). Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation. OncoTargets and Therapy. 9. 1753–1753. 7 indexed citations
8.
Tanaka, Hiroki, Masaki Yamashita, Manabu Ishii, et al.. (2016). A case of Takayasu's arteritis detected in a patient with Crohn's disease following infliximab treatment.. PubMed. 113(10). 1761–1768. 3 indexed citations
9.
Ninomiya, Kiichiro, Katsuyuki Hotta, Eiki Ichihara, et al.. (2015). Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201. International Journal of Clinical Oncology. 21(1). 81–87. 23 indexed citations
11.
Kuroda, Naoto, Yoji Nagashima, Masahiro Yao, et al.. (2015). Immunohistochemical characterization of renal tumors in patients with Birt‐Hogg‐Dubé Syndrome. Pathology International. 65(3). 126–132. 14 indexed citations
12.
Ogino, Jiro, Hiroko Asanuma, Yutaka Hatanaka, et al.. (2013). Validity and reproducibility of Ki‐67 assessment in gastrointestinal stromal tumors and leiomyosarcomas. Pathology International. 63(2). 102–107. 12 indexed citations
13.
Furuya, Mitsuko, Reiko Tanaka, Shunsuke Koga, et al.. (2012). Pulmonary Cysts of Birt-Hogg-Dubé Syndrome. The American Journal of Surgical Pathology. 36(4). 589–600. 72 indexed citations
14.
Kuroda, Naoto, Hiroko Gotoda, Chisato Ohe, et al.. (2011). Review of juxtaglomerular cell tumor with focus on pathobiological aspect. Diagnostic Pathology. 6(1). 80–80. 43 indexed citations
15.
Hasegawa, Takayuki, et al.. (2010). 708 PROSTATE CANCER LOCALIZATION WITH MRI AND I MRI-TARGETED TRANSPERINEAL TEMPLATE BIOPSY (MTTB). European Urology Supplements. 9(2). 231–232. 1 indexed citations
17.
Furuno, T., Hiroko Gotoda, Shunji Muraoka, et al.. (2003). Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. The Prostate. 58(1). 76–81. 52 indexed citations
18.
Ohyama, Makiko, et al.. (2000). Mesenchymal dysplasia of the placenta. Pathology International. 50(9). 759–764. 43 indexed citations
19.
Gotoda, Hiroko, Miri Fujita, Kazuo Nagashima, et al.. (1996). Cerebral germinoma with marked granulomatous inflammation: Granulomatous germinoma. Neuropathology. 16(3). 165–171. 9 indexed citations
20.
Saito, Hitomi, et al.. (1991). [Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].. PubMed. 18(13). 2315–24. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026